NCT06011304View on ClinicalTrials.gov

Study of 18F-Florastamin PET/CT Imaging in Patients With at Least Intermediate Risk Prostate Cancer

PHASE3RecruitingINTERVENTIONAL
Enrollment

267

Participants

Timeline

Start Date

October 20, 2023

Primary Completion Date

November 30, 2024

Study Completion Date

January 31, 2025

Conditions
Prostate Cancer
Interventions
DRUG

[18F]Florastamin Injection

"The subjects who participate in phase 3 study will be intravenously injected with \[18F\]Florastamin Injection and undergo PET/CT scan at 110 min after the injection.~Subjects who participate in pilot study will be intravenously injected with \[18F\]Florastamin Injection and undergo PET/CT scan at 5 min, 30 min, 60 min, 110 min, 160 min after the injection."

Trial Locations (1)

Unknown

RECRUITING

Sun Yat-sen University Cancer Center, Guangzhou

All Listed Sponsors
lead

HTA Co., Ltd.

INDUSTRY